Notably, SAMHD1 has also been reported to protect cells from build‐up of cytotoxic dGTP, which could be exploited to target SAMHD1‐deficient cancer cells with PNP inhibitors [155, 156]. The gene discussed is SAMHD1; the disease is cancer.